SIEGALL CLAY B (President and CEO) purchased 20.5% of their position (137.10K shares) of IMMUNOME INC. on the open market
Open‑market purchase worth $999.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/26/2025ACC: 0001415889-25-009017
DirectorOfficer· President and CEO
Since Oct 2023
+137.10K
Net shares
Net buyer
$999.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
137.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+137.10K
Price / share
$7.29
Trade value
$999.46K
% of position
20.5%
3/26/2025
669.64K→806.74K
Total
Net shares
+137.10K
Net value
$999.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2025 | P · Purchase | +137.10K | $7.29 | $999.46K | 20.5% | 669.64K | 806.74K |
| Total | +137.10K | $999.46K | ||||||
Derivative Transactions0
No derivative transactions reported